European Companies Search Engine
EU funding (€2,124,000): Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). Hor1 Mar 2016 EU Research and Innovation programme "Horizon"
Overview
Text
Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).
MAST4HEALTH is set on the concept of a multidisciplinary approach to assess a non-pharmacological intervention for managing NAFLD/NASH, one of the most common complications of obesity and diabetes mellitus in Western populations affecting approximately 50% of diabetics and 76% of obese patients. Because of limitations in current NAFLD treatment therapies, many new efforts focus on exploring non-pharmacologic means for managing the disease and in particular through dietary substances or bioactive phytochemicals in fruits, vegetables, and plants or their products. MAST4HEALTH aims at exploring the effect of Mastiha, a natural product of Greece which was recently shown to possess antioxidant/anti-inflammatory and lipid lowering properties. We designed a multicenter randomized double blind placebo controlled (parallel arm) clinical trial to test the effectiveness of Mastiha supplement as new non-pharmacologic strategy for NAFLD/NASH treatment. MAST4HEALTH will explore gene-diet interactions, more specifically the potential personalized activity of the Mastiha, and correlate genetic and epigenetic markers with metabolomic and intestinal microbiota profiles pre- and post-intervention. The effectiveness of the proposed intervention will be evaluated via clinical and laboratory markers of the disease. To this end, MAST4HEALTH will train a number of researchers and PhD students in multidisciplinary approaches of this survey. MAST4HEALTH is expected to build and enhance cooperation among partners meanwhile strengthening the interaction between our academic and non-academic sectors
Funded Companies:
| Company name | Funding amount |
| Biotech Vana SL | €157,500 |
| Charokopeio Panepistimio | €441,000 |
| Consiglio Nazionale Delle Ricerche | €121,500 |
| Enosis Mastichoparagogon Chiou | €297,000 |
| Fondazione Irccs CA' Granda - Ospedale Maggiore Policlinico | €9,000.00 |
| Fundacion para El Fomento de La Investigacion Sanitaria y Biomedica de La Comunitat Valenciana | €117,000 |
| Institut National de la Sante et de la Recherche Medicale | €135,000 |
| Marascio Fernando | €108,000 |
| Perspectum Ltd. | €157,500 |
| Queen Mary University of London | €162,000 |
| Randox Laboratories Ltd. | €153,000 |
| SANOFI-AVENTIS DEUTSCHLAND GmbH | €81,000 |
| Universita Degli Studi Di Milano | €63,000 |
| University OF Novi SAD, Faculty OF Medicine Novi SAD | €108,000 |
| Univerzitet U Istocnom Sarajevu | €13,500.00 |
Source: https://cordis.europa.eu/project/id/691042
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Biotech Vana SL - EU funding (€2,124,000): Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH)."
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
